Epoxy fatty acid dysregulation and neuroinflammation in Alzheimer’s disease is resolved by a soluble epoxide hydrolase inhibitor
Anamitra Ghosh(Wave Life Sciences (United States)), Hui Zheng(Hunan University)
Cited by 7
Related Papers
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
|Journal of Neuroscience|2016|600
Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease
|Neuron|2018|525
Practical considerations for choosing a mouse model of Alzheimer’s disease
|Molecular Neurodegeneration|2017|455
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
|Journal of Clinical Investigation|2020|246